Cabot (NYSE:CBT) Price Target Raised to $70.00 at JPMorgan Chase & Co.

Cabot (NYSE:CBT) had its price objective lifted by JPMorgan Chase & Co. from $68.00 to $70.00 in a report released on Wednesday morning,Benzinga reports. They currently have an underweight rating on the specialty chemicals company’s stock.

Other equities research analysts also recently issued reports about the company. Mizuho boosted their target price on Cabot from $75.00 to $80.00 and gave the stock a “neutral” rating in a research report on Wednesday, May 6th. Wall Street Zen upgraded Cabot from a “hold” rating to a “buy” rating in a research report on Saturday, May 9th. Zacks Research upgraded Cabot from a “strong sell” rating to a “hold” rating in a research report on Tuesday, January 27th. UBS Group boosted their target price on Cabot from $81.00 to $86.00 and gave the stock a “neutral” rating in a research report on Friday, May 8th. Finally, Jefferies Financial Group reiterated a “buy” rating and issued a $85.00 target price on shares of Cabot in a research report on Wednesday, February 4th. One analyst has rated the stock with a Buy rating, four have assigned a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $80.25.

Cabot Price Performance

NYSE:CBT opened at $82.99 on Wednesday. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. The company has a market capitalization of $4.28 billion, a P/E ratio of 15.69, a P/E/G ratio of 11.06 and a beta of 0.78. Cabot has a 12 month low of $58.33 and a 12 month high of $86.43. The business’s 50-day moving average is $74.61 and its 200 day moving average is $70.81.

Cabot (NYSE:CBT) last posted its earnings results on Tuesday, May 5th. The specialty chemicals company reported $1.61 EPS for the quarter, topping analysts’ consensus estimates of $1.47 by $0.14. The company had revenue of $904.00 million for the quarter, compared to the consensus estimate of $900.31 million. Cabot had a return on equity of 21.33% and a net margin of 7.97%.The firm’s revenue for the quarter was down 3.4% on a year-over-year basis. During the same period in the previous year, the business earned $1.90 earnings per share. Cabot has set its FY 2026 guidance at 6.000-6.50 EPS. On average, equities research analysts forecast that Cabot will post 6.32 earnings per share for the current fiscal year.

Cabot Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 12th. Stockholders of record on Friday, May 29th will be paid a dividend of $0.4725 per share. This is a positive change from Cabot’s previous quarterly dividend of $0.45. This represents a $1.89 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Friday, May 29th. Cabot’s payout ratio is currently 34.03%.

Institutional Inflows and Outflows

A number of hedge funds have recently modified their holdings of CBT. Norges Bank bought a new position in Cabot in the fourth quarter worth approximately $49,662,000. AQR Capital Management LLC grew its stake in Cabot by 123.0% in the second quarter. AQR Capital Management LLC now owns 867,946 shares of the specialty chemicals company’s stock worth $65,096,000 after purchasing an additional 478,702 shares in the last quarter. UBS Group AG grew its stake in Cabot by 186.7% in the third quarter. UBS Group AG now owns 593,510 shares of the specialty chemicals company’s stock worth $45,136,000 after purchasing an additional 386,514 shares in the last quarter. Pacer Advisors Inc. grew its stake in Cabot by 3,165.7% in the fourth quarter. Pacer Advisors Inc. now owns 229,252 shares of the specialty chemicals company’s stock worth $15,195,000 after purchasing an additional 222,232 shares in the last quarter. Finally, American Century Companies Inc. grew its stake in Cabot by 8.4% in the third quarter. American Century Companies Inc. now owns 1,805,393 shares of the specialty chemicals company’s stock worth $137,300,000 after purchasing an additional 140,665 shares in the last quarter. Institutional investors own 93.18% of the company’s stock.

Cabot Company Profile

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.